To the Editor,

The article 'Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society' by Kapoor et al. \[[@bib1]\] is a much-needed guideline for use of hydroxychloroquine (HCQ) in the current COVID-19 pandemic. It recommends performing a baseline electrocardiograph (ECG) and calculation QT~c~ prior to starting HCQ.

Based on the existing evidences, though not conclusive, HCQ has been recommended for use as prophylaxis and treatment of COVID-19 in many guidelines. Although it is a safe drug, a serious adverse effect is QT prolongation, culminating in Torsades des Pointes or polymorphic ventricular tachycardia, leading to sudden cardiac death. Unfortunately, only few published literatures speak about the adverse reaction and precautions to be taken before using the drug ([Table 1](#tbl1){ref-type="table"} ).Table 1The available literature on hydroxychloroquine induced electrocardiographic changes and current recommendations.Table 1No.Study/Recommendation/GuidelineUpdated/PublishedRecommendation1Indian pacing and electrophysiology journal \[[@bib1]\]April, 2020**Recommends baseline ECG in all and Bazett formula**2CDC \[[@bib3]\]April 7, 2020Follow FDA approval recommendation3FDA \[[@bib4]\]March 28, 2020No recommendation4European medicine agenciesApril 7, 2020No recommendation (against use)5The centre for evidence-based medicineMarch 25, 2020No recommendation6American College of Cardiology \[[@bib5]\]March 29, 2020Fridericia/Framingham formula for QTc7ICMRMarch 21, 2020No recommendation8BMJ- best practise \[[@bib3]\]April 7, 2020No recommendation9WHO- Landscape analysis of therapeutics \[[@bib3]\]March 21, 2020No recommendation[^1]

It is well known fact that QT~c~ is calculated using various formulae viz., Bazett, Fridericia, Framingham, Hodges and Rautaharju. For drug induced QT~c~ prolongation, the study by Vanderberk et al. advocated to use Fridericia or Framingham formula instead of Bazett formula, which may under correct QT~c~ prolongation at low heart rate and overcorrect at high heart rate \[[@bib2]\]. However, the Indian heart rhythm society \[[@bib1]\] has recommended use of Bazett formula. In view of lack of studies comparing various formulae on a head-to-head basis and ease of using online calculators, the reason for choosing the particular formula is unclear. There is an urgent need to carry out further studies to look into the occurrence of Torsades de pointes and QTc prolongation with HCQ using various formulae and develop international guidelines for the same.
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[^1]: CDC- Centre for disease control, FDA- Food and Drug Administration, ICMR- Indian council of medical research, BMJ- British medical journal, WHO- World health organisation.
